Thursday, June 09, 2011

FDA Warning About Topamax

March 4, 2011 – The Food and Drug Administration (FDA) has issued a safety announcement concerning the risks to fetuses when women take Topamax (topiramate) while pregnant.

The announcement is based on new information collected from human data since the drug was released. The data has lead the FDA to reclassify topiramates such as Topamax, from a Pregnancy Category C drug, that may cause birth defects, to a Pregnancy Category D drug that has showen positive evidence for risks to the fetus based on data gathered from human usage. Such birth defects would be incurred during the first trimester of pregnancy, when many women may not yet realize they are pregnant.

If you took Topamax while pregnant, personal injury lawyers O’Hanlon, McCollom & Demerath would like to invite you to contact them for a consultation. You could have just cause to file a Topamax lawsuit for compensation to assist in paying the costly medical bills needed to treat your child's birth defect.

O’Hanlon, McCollom & Demerath
Personal Injury Lawyers
808 West Avenue
Austin, TX. 78701

phone: 512-494-9949

Note that in their safety announcement the FDA stated that there are cases where the risks of taking Topamax, and other topiramates, by pregnant women may be acceptable due to the specific benefits of the drug in the treatment of epileptic seizures.